# Ysios Capital's Biotech Investments: 15 Startups in Its Portfolio (2026) > The 15 Biotech startups Ysios Capital has backed, by stage: $1.7B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/ysios-capital-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 7 - [CVRx](https://millionrounds.com/company/cvrx) - [Galecto](https://millionrounds.com/company/galecto) - [AM Pharma](https://millionrounds.com/company/am-pharma) - [*B* BioVex](https://millionrounds.com/company/biovex) - [SANIFIT](https://millionrounds.com/company/sanifit) - [*AB* Aura Biosciences](https://millionrounds.com/company/aura-biosciences) - [Anaconda Biomed](https://millionrounds.com/company/anaconda-biomed) ## Series B 5 - [Ona Therapeutics](https://millionrounds.com/company/ona-therapeutics) - [MedLumics](https://millionrounds.com/company/medlumics) - [Prexton Therapeutics](https://millionrounds.com/company/prexton-therapeutics) - [*M* Minoryx](https://millionrounds.com/company/minoryx) - [*B* BioClin](https://millionrounds.com/company/bioclin) ## Series A 3 - [Minoryx Therapeutics](https://millionrounds.com/company/minoryx-therapeutics) - [*C* Cardoz](https://millionrounds.com/company/cardoz) - [Inbiomotion](https://millionrounds.com/company/inbiomotion) ## Segment by segment ### Series C and later 7 startups · $1.4B raised - [**CVRx**](https://millionrounds.com/company/cvrx) CVRx is a medical device company developing implantable technology for the treatment of high blood pressure. United States $369M - [**Galecto**](https://millionrounds.com/company/galecto) Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer. Denmark $365M - [**AM Pharma**](https://millionrounds.com/company/am-pharma) AM-Pharma is a Dutch clinical-stage biopharmaceutical company founded in 2001 and based in Utrecht, Netherlands. Netherlands $189M - [*B* **BioVex**](https://millionrounds.com/company/biovex) THOUSAND OAKS, Calif., March 4, 2011 /PRNewswire via COMTEX/ -- Amgen (Nasdaq: AMGN), today announced the completion of the acquis United Kingdom $133M - [**SANIFIT**](https://millionrounds.com/company/sanifit) SANIFIT is a biotechnology company that develops treatments for patients with calcification disorders. Spain $122M - [*AB* **Aura Biosciences**](https://millionrounds.com/company/aura-biosciences) United States $112M - [**Anaconda Biomed**](https://millionrounds.com/company/anaconda-biomed) Anaconda BioMed S.L. Spain $73M ### Series B 5 startups · $226M raised - [**Ona Therapeutics**](https://millionrounds.com/company/ona-therapeutics) Ona Therapeutics is a clinical-stage biotechnology company based in the Barcelona Science Park, Spain. Spain $98M - [**MedLumics**](https://millionrounds.com/company/medlumics) Medlumics is a startup employing biophotonic technologies to develop products that improve human living standards. Spain $42M - [**Prexton Therapeutics**](https://millionrounds.com/company/prexton-therapeutics) Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life. Switzerland $41M - [*M* **Minoryx**](https://millionrounds.com/company/minoryx) Spain $25M - [*B* **BioClin**](https://millionrounds.com/company/bioclin) - $20M ### Series A 3 startups · $77M raised - [**Minoryx Therapeutics**](https://millionrounds.com/company/minoryx-therapeutics) Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases. Spain $57M - [*C* **Cardoz**](https://millionrounds.com/company/cardoz) Cardoz AB, based in Stockholm, Sweden, manufactures anti-inflammatory pharmaceuticals to combat heart and vascular disorders. Sweden $18M - [**Inbiomotion**](https://millionrounds.com/company/inbiomotion) Inbiomotion is a biotechnology company based in Barcelona that specializes in precision medicine. Spain $2.5M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Ysios Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with Ysios Capital** 18 co-investors](https://millionrounds.com/portfolio-maps/ysios-capital-co-investors)[Sector portfolio **K Fund's AI portfolio** 66 startups · $658M](https://millionrounds.com/portfolio-maps/kfund-ai-portfolio)[Sector portfolio **Inveready's Biotech portfolio** 13 startups · $142M](https://millionrounds.com/portfolio-maps/inveready-biotech-portfolio)[Sector portfolio **Alma Mundi Ventures' Fintech portfolio** 13 startups · $883M](https://millionrounds.com/portfolio-maps/alma-mundi-ventures-fintech-portfolio)[Sector portfolio **K Fund's Fintech portfolio** 13 startups · $69M](https://millionrounds.com/portfolio-maps/kfund-fintech-portfolio)[Sector portfolio **K Fund's Healthtech portfolio** 10 startups · $102M](https://millionrounds.com/portfolio-maps/kfund-healthtech-portfolio) ## Raising from investors like Ysios Capital? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)